Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-274241
Filing Date
2025-11-10
Accepted
2025-11-10 16:11:00
Documents
76
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fgen-20250930.htm   iXBRL 10-Q 3363999
2 EX-10.1 fgen-ex10_1.htm EX-10.1 58413
3 EX-10.2 fgen-ex10_2.htm EX-10.2 268706
4 EX-10.3 fgen-ex10_3.htm EX-10.3 82167
5 EX-31.1 fgen-ex31_1.htm EX-31.1 10443
6 EX-31.2 fgen-ex31_2.htm EX-31.2 10437
7 EX-32.1 fgen-ex32_1.htm EX-32.1 10431
  Complete submission text file 0001193125-25-274241.txt   12698652

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT fgen-20250930.xsd EX-101.SCH 1986805
79 EXTRACTED XBRL INSTANCE DOCUMENT fgen-20250930_htm.xml XML 1923800
Mailing Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133
Business Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36740 | Film No.: 251466289
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)